Whether you're new to GLP-1 medications like Zepbound, Wegovy, Mounjaro or Ozempic, or just looking to optimize your results, this podcast is your trusted space for expert insights, real success stories, and practical strategies to help you feel your best
Glucagon-like-peptide-1 (GLP-1) agonists are a group of drugs approved for use in management of type-2 diabetes and obesity
GLP-1 (Glucagon-like Peptide-1) receptor agonists, such as Semaglutide GLP-1 and Liraglutide (Victoza), are increasingly becoming an integral part of our treatment strategies
The currently available incretin-based therapies are listed in Table 1 , and their physiologic effects are summarized in Figure 1
Built on foundational TNF receptor research by Professor David Wallach at the Weizmann Institute
You must also meet BMI requirements (30 or 27 with weight-related comorbidities) and pass medical screening for contraindications